HFAR

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Efficacy and Safety of Anti-angiogenic Therapy With IV Bevacizumab in Patients With Symptomatic Cerebral Arteriovenous Malformations	Cardiovascular Abnormalities, Central Nervous System Vascular Malformations, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, arteriovenous hemangioma/malformation, arteriovenous malformations of the brain, brain disorder, cardiovascular disorder, central nervous system disorder, central nervous system malformation, cerebrovascular disorder, intracranial arterial disease, nervous system disorder, vascular disorder, vascular malformation	Recruiting	Phase 2 / Phase 3	2026-01-22		NCT06264531

Clinical trials